Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Announces Two Orders for Microwave Synthesis Technology

NEW YORK, Oct. 13 (GenomeWeb News) - Pyrosequencing, of Uppsala, Sweden, said today that it has received orders for microwave synthesis scale-up technology from two major pharmaceutical companies. 


The total value of the two orders is roughly $651,903, according to the company.


"Pharma companies are now showing explicit interest in scale-up microwave technology, because the possibility to directly transfer lab-scale results to a scale suitable for the next stage of drug development is unique and highly valuable to them," Jon-Sverre Schanche, vice president of R&D for Pyrosequencing, said in a statement.



The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more